Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Colorcon
AstraZeneca
Medtronic
Dow

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Litigation Details for Purdue Pharma L.P. v. Amneal Pharmaceuticals, LLC (S.D.N.Y. 2013)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Purdue Pharma L.P. v. Amneal Pharmaceuticals, LLC (S.D.N.Y. 2013)

Docket   Start Trial Date Filed 2013-05-17
Court District Court, S.D. New York Date Terminated 2015-04-09
Cause 35:271 Patent Infringement Assigned To Sidney H. Stein
Jury Demand None Referred To
Parties AMNEAL PHARMACEUTICALS, LLC; PURDUE PHARMA L.P.; PURDUE PHARMACEUTICALS, LLC; THE P.F. LABORATORIES, INC.
Patents 4,389,393; 4,588,580; 4,861,598; 5,240,711; 5,266,331; 5,474,995; 5,508,042; 5,549,912; 5,656,295; 5,968,551; 6,488,963; 7,201,920; 7,776,314; 8,075,872; 8,114,383; 8,192,722; 8,337,888
Attorneys Pablo Daniel Hendler; Robert J. Goldman; Sona De; Stuart David Sender
Link to Docket External link to docket
Small Molecule Drugs cited in Purdue Pharma L.P. v. Amneal Pharmaceuticals, LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Purdue Pharma L.P. v. Amneal Pharmaceuticals, LLC (S.D.N.Y. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-05-17 1 1981 Ludwigetal. 4,385,057 A 5/1983 Bjork et al. 4,389,393 A 6/1983 Schoretal. 4,424,205 A 1/1984 Lal'…ACTION l. This is an action for patent infringement arising under the patent laws of the United States, Title…this Judicial District in patent litigation concerning United States Patent Nos. 7,674,799, 7,674,800,…act of infringement of the ‘888 patent'under the United States Patent Law, 35 U.S.C. § 271(e)(2)(A) …8,337,888 132 *Dec. 25, 2012 (io) Patent No.: (45) Date of Patent: (54) PHARMACEUTICAL FORMULATION External link to document
2014-05-27 26 Court’s prior construction of U.S.  Patent No. 7,776,314 (“‘314 Patent”), which recites a gelling requirement…,383 (“the ‘383 Patent”).2 ‘060  Patent at [62]. Like the ‘383 patent, the ‘060 Patent discloses and claims… The two patents before the Court are Purdue’s U.S. Patent No.  8,337,888 (“’888 Patent”) (Ex. 1 to…Compare ’060 Patent at 2:17–32, 21:13–14, with  ‘383 Patent at 2:7–13, 21:1–14. The ‘060 Patent names several…hardening agents. ‘060 Patent at 5:54–63. Unlike  the ‘383 Patent, however, the ‘060 Patent includes claims  External link to document
2015-04-08 67 Pharmaceuticals L.P.: Claims 5, 7, 23, and 24 of U.S. Patent No. 8,337,888 are invalid. 3. Amneal' s counterclaim for…non-infringementof claims 5, 7, 23, and 24 of U.S. Patent No. 8,337,888 is denied. 4. No attorney's fees will be…2013 9 April 2015 1:13-cv-03372-SHS Patent None District Court, S.D. New External link to document
2015-04-09 68 Notice of Right to Appeal Pharmaceuticals L.P.: Claims 5,7,23, and 24 of U.S. Patent No. 8,337,888 are invalid.3. Amneal's counterclaim for…non-infringement of claims 5,7,23, and 24 of U.S. Patent No. 8,337,888 is denied. 4. No attorneys fees will be …2013 9 April 2015 1:13-cv-03372-SHS Patent None District Court, S.D. New External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Baxter
Merck
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.